Action By Pharmacia & Upjohn To Improve

4 May 1997

A pledge to improve performance was made by Richard Brown, Pharmacia &Upjohn's chairman, when the company announced its financial results for the first three months of 1997. P&U had previously warned that the performance would not be good (Marketletter April 28).

Jan Ekberg, president and chief executive, said: "a number of actions have been implemented and others are now being launched" which will "significantly improve short- and long-term results of this company." Furthermore, the firm indicated that it has progressed in its search for a new chief executive, and expects to make an announcement in the near future.

Sales in the quarter were down 6.1% to $1.6 billion, net earnings declined 15.3% to $194 million before nonrecurring items, and earnings per share were down 15.9% to 37 cents. 5% of the sales decline was attributed to foreign exchange effects and trade inventory building.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight